FY19 JPC-2/midrp support services - base

Ended Awarded Last action

Contract number
W81XWH19F0159
Awardee
Awarding agency
Obligated
$246,996

Award facts

Opportunity
Contract value 61% obligated
$403,329.50 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Medical Command Department of the Army, Department of Defense
Set-aside
No set-aside
Competition
Full and Open Competition Two Step
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21702, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00008 · Meeting support services. -$121,014
Funding Only Action P00007 · Military infectious disease research program (midrp) support services -$112,210
Exercise an Option P00006 · FY22 JPC-2/midrp support services - OY3 $102,000
Change Order P00005 $0
Exercise an Option P00004 $97,321
Change Order P00003 · FY20 JPC-2/midrp support services - OY1 $0
Change Order P00002 -$66,335
Exercise an Option P00001 · FY20 JPC-2/midrp support services - OY1 - meeting, scientific, and administrative support services $143,258
Original award $203,976

About this award

Leidos, Inc. received a $579,739.40 delivery order awarded on February 27, 2019, to provide support services for the Military Infectious Disease Research Program (MIDRP) under a contract with the U.S. Army Medical Command. This cost-plus-fixed-fee delivery order, which was completed on February 26, 2023, was not designated as a set-aside contract. The work was performed in Frederick, Maryland, a location historically significant to military medical research. Under this delivery order, Leidos provided technical and administrative support to advance MIDRP's research initiatives addressing infectious diseases of military significance. Strategy Arts, LLC served as a subcontractor, providing consulting services to support the statement of work requirements between July 2020 and July 2020.

The Military Infectious Disease Research Program is a Department of Defense research initiative focused on addressing infectious disease threats to military personnel and readiness. Leidos' engagement through its Services Operating Segment, which operates under the SAIC brand, demonstrates the company's established role in supporting critical military medical research. As the child entity of Leidos Holdings, Inc., the awardee leveraged its broader corporate capabilities in medical research support to execute this contract. The delivery order structure allowed the Army Medical Command to task specific work requirements under an existing contract vehicle, enabling flexible allocation of resources to address evolving research priorities within the MIDRP portfolio.

Quick answers

Who was awarded contract W81XWH19F0159?

W81XWH19F0159 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on February 27, 2019.

How much is contract W81XWH19F0159 worth?

The government has obligated $246,996 on W81XWH19F0159. Its current value, with exercised options, is $403,330.

Which agency awarded contract W81XWH19F0159?

Defense Health Agency (Department of Defense) awarded W81XWH19F0159, with funding from Medical Command (Department of the Army).

Is contract W81XWH19F0159 an order under another contract?

Yes. W81XWH19F0159 is a delivery order under W81XWH17D0025, an indefinite delivery contract.

Was contract W81XWH19F0159 competed?

The extent of competition for W81XWH19F0159 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award